JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 28 No. 8 1322-1329
© 1987 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosamond, T. L.
Right arrow Articles by Fox, K. A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosamond, T. L.
Right arrow Articles by Fox, K. A. A.

Metabolic Fate of Radiolabeled Palmitate in Ischemic Canine Myocardium: Implications for Positron Emission Tomography

Thomas L. Rosamond, Dana R. Abendschein, Burton E. Sobel, Steven R. Bergmann and Keith A. A. Fox

Cardiovascular Division, Washington University School of Medicine, St. Louis Missouri

Correspondence: For reprints contact: Thomas L. Rosamond, MD, Cardiovascular Div, Washington University School of Medicine, 660 South Euclid Ave., Box 8086, St. Louis, MO 63110.

ABSTRACT

Interpretation of dynamic and integrated myocardial tomograms requires elucidation of the biochemical fate of the tracer and characterization of its tissue distribution and rate of efflux. The fate of [1-11C] and [1-14C] palmitate was studied in 13 open-chest dogs during control or ischemic extracorporeal perfusion of the left circumflex coronary artery. Residue detection of myocardial radioactivity, and radio-biochemical analyses of sequential transmural biopsies and arterial and coronary venous effluent were performed for 30 min after intracoronary bolus administration of tracer. In control hearts, 10.3% of initially extracted tracer was retained in tissue (2.9% in triglyceride, 3.5% in phospholipid, and 3.9% in other lipid and aqueous fractions), 73.7% was oxidized, and 16.1% back-diffused unaltered. With ischemia (pump flow 10% of normal). 28.1% was retained (18% in triglyceride, 6.0% in phospholipid, and 4.1% in other lipid and aqueous fractions), 27.2% was oxidized, and 44.4% back diffused (p < 0.05 compared to control). Throughout the 30-min study interval, triglyceride, diglyceride, and nonesterified fatty acid comprised a significantly greater fraction of initially extracted radioactivity in ischemic than in control hearts. Thus, during ischemia externally detected clearance rates cannot be used as a direct measure of fatty acid metabolism because of marked influences on efflux of nonmetabolized radiolabeled palmitate and the distribution of tracer retained in tissue. Quantitative measurements of specific metabolic processes by tomography will require development and validation of tracers confined to individual metabolic pathways or pools.




This article has been cited by other articles:


Home page
JNMHome page
C. Q. Shi, L. H. Young, E. Daher, E. V.R. DiBella, Y.-H. Liu, E. N. Heller, S. Zoghbi, F. J.Th. Wackers, R. Soufer, and A. J. Sinusas
Correlation of Myocardial p-123I-Iodophenylpentadecanoic Acid Retention with 18F-FDG Accumulation During Experimental Low-Flow Ischemia
J. Nucl. Med., March 1, 2002; 43(3): 421 - 431.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Kaneta, Y. Takai, Y. Kagaya, Y. Yamane, H. Wada, M. Yuki, R. Iwata, M. Tsujitani, S. Takahashi, and S. Yamada
Imaging of Ischemic but Viable Myocardium Using a New 18F-Labeled 2-Nitroimidazole Analog, 18F-FRP170
J. Nucl. Med., January 1, 2002; 43(1): 109 - 116.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
R M Quinlivan, R O Robinson, and M N Maisey
Positron emission tomography in paediatric cardiology
Arch. Dis. Child., December 1, 1998; 79(6): 520 - 522.
[Full Text]


Home page
CirculationHome page
I. M. Straeter-Knowlen, W. T. Evanochko, J. A. den Hollander, P. E. Wolkowicz, J. A. Balschi, J. B. Caulfield, D. D. Ku, and G. M. Pohost
1H NMR Spectroscopic Imaging of Myocardial Triglycerides in Excised Dog Hearts Subjected to 24 Hours of Coronary Occlusion
Circulation, April 1, 1996; 93(7): 1464 - 1470.
[Abstract] [Full Text]


Home page
NEJMHome page
B. L. Zaret and F. J. Wackers
Nuclear Cardiology- Second of Two Parts
N. Engl. J. Med., September 16, 1993; 329(12): 855 - 863.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1987 by the Society of Nuclear Medicine.